PCN100 HEALTH-ECONOMIC EVALUATION OF LUNG CANCER DRUGS: DO S AND DON TS IN FRANCE

Autor:	C. Godard, S. Roze, R. Sellami, M. Sivignon
Rok vydání:	2019
Předmět:	Oncology medicine.medical_specialty business.industry Health Policy Internal medicine Economic evaluation Public Health Environmental and Occupational Health medicine business Lung cancer medicine.disease
Zdroj:	Value in Health. 22:S455
ISSN:	1098-3015
DOI:	10.1016/j.jval.2019.09.297
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::081562de809cbb47651c7a735de024e4 https://doi.org/10.1016/j.jval.2019.09.297 Zobrazit plný text záznamu Full Text from ScienceDirect